104 related articles for article (PubMed ID: 2668037)
21. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study.
Kapoor S; Pal S; Sahni P; Dattagupta S; Kanti Chattopadhyay T
J Surg Res; 2005 Dec; 129(2):172-5. PubMed ID: 15882879
[TBL] [Abstract][Full Text] [Related]
22. [Blood transfusions and prognosis following curative resection of colorectal cancer: is there an association?].
Laffer U; Jäggi P; Harder F; Metzger U; Egeli R; Weber W; Barras JP; Schweizer W; Müller W; Martinoli S
Helv Chir Acta; 1989 Dec; 56(4):461-4. PubMed ID: 2632470
[TBL] [Abstract][Full Text] [Related]
23. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival.
Kwon AH; Matsui Y; Kamiyama Y
Cancer; 2001 Feb; 91(4):771-8. PubMed ID: 11241245
[TBL] [Abstract][Full Text] [Related]
24. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer.
Wigmore SJ; McMahon AJ; Sturgeon CM; Fearon KC
Br J Surg; 2001 Feb; 88(2):255-60. PubMed ID: 11167877
[TBL] [Abstract][Full Text] [Related]
25. Clinical experience of blood transfusion in renal transplantation.
Frisk B; Berglin E; Blohmé I; Persson H; Sandberg L; Wedel N; Brynger H
Scand J Urol Nephrol Suppl; 1984; 88():1-69. PubMed ID: 6399773
[TBL] [Abstract][Full Text] [Related]
26. Blood transfusion and the risk of recurrence in stage IB cervical cancer.
Morris PC; Haugen J; Tomjack J; Anderson B; Buller RE
Gynecol Oncol; 1995 Jun; 57(3):401-6. PubMed ID: 7774845
[TBL] [Abstract][Full Text] [Related]
27. Recurrence and survival after potentially curative surgery for colorectal cancer.
Jadallah F; McCall JL; van Rij AM
N Z Med J; 1999 Jul; 112(1091):248-50. PubMed ID: 10448981
[TBL] [Abstract][Full Text] [Related]
28. Indication and efficacy of adjuvant chemotherapy with oral fluoropyrimidines for dukes' B colorectal cancer.
Yoshimatsu K; Umehara A; Ishibashi K; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
Anticancer Res; 2006; 26(4B):3089-93. PubMed ID: 16886639
[TBL] [Abstract][Full Text] [Related]
29. Multidisciplinary treatment of colorectal cancer in New Zealand: survival rates from 1997-2002.
Keating J; Yong D; Cutler G; Johnston J
N Z Med J; 2006 Sep; 119(1242):U2238. PubMed ID: 16998579
[TBL] [Abstract][Full Text] [Related]
30. Colorectal cancer among patients aged 75 years or over.
Araujo SE; de Paris Caravatto PP; de Campos FG; da Silva e Sousa AH; Nahas SC; Kiss DR; Cecconello I
Hepatogastroenterology; 2007 Mar; 54(74):427-30. PubMed ID: 17523289
[TBL] [Abstract][Full Text] [Related]
31. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome.
Nakafusa Y; Tanaka T; Tanaka M; Kitajima Y; Sato S; Miyazaki K
Dis Colon Rectum; 2004 Dec; 47(12):2055-63. PubMed ID: 15657654
[TBL] [Abstract][Full Text] [Related]
32. Targets and elective colorectal cancer: outcome and symptom delay at surgical resection.
Bharucha S; Hughes S; Kenyon V; Anderson ID; Carlson GL; Scott NA
Colorectal Dis; 2005 Mar; 7(2):169-71. PubMed ID: 15720357
[TBL] [Abstract][Full Text] [Related]
33. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
[TBL] [Abstract][Full Text] [Related]
34. Perioperative blood transfusions, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence.
van de Watering LM; Brand A; Houbiers JG; Klein Kranenbarg WM; Hermans J; van de Velde C;
Br J Surg; 2001 Feb; 88(2):267-72. PubMed ID: 11167879
[TBL] [Abstract][Full Text] [Related]
35. Operative blood loss and use of blood products after laparoscopic and conventional open colorectal operations.
Kiran RP; Delaney CP; Senagore AJ; Millward BL; Fazio VW
Arch Surg; 2004 Jan; 139(1):39-42. PubMed ID: 14718273
[TBL] [Abstract][Full Text] [Related]
36. Preoperative hypoxyradiotherapy of colorectal carcinoma.
Tacev T; Skricka T; Zaloudík J; Pacovský Z
Strahlenther Onkol; 2002 Dec; 178(12):676-81. PubMed ID: 12491055
[TBL] [Abstract][Full Text] [Related]
37. Survival after hepatic resection in metastatic colorectal cancer: a population-based study.
Cummings LC; Payes JD; Cooper GS
Cancer; 2007 Feb; 109(4):718-26. PubMed ID: 17238180
[TBL] [Abstract][Full Text] [Related]
38. Colorectal cancer patterns of care in the Western Sydney and Wentworth Area Health Services.
Barton MB; Gabriel GS; Miles S
ANZ J Surg; 2004 Jun; 74(6):406-12. PubMed ID: 15191469
[TBL] [Abstract][Full Text] [Related]
39. [Meta-analysis of postoperative adjuvant chemotherapy for Dukes' B colorectal carcinoma].
Wan XB; Pan ZZ; Chen G; Li LR; Wan DS
Ai Zheng; 2005 May; 24(5):600-4. PubMed ID: 15890106
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
